StockData
Axogen, Inc. logo

Axogen, Inc. (AXGN) income statement

AXGNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/30152% above fair value
$56.95+1.58 (+2.85%)

Close on Nov 18, 2026Market cap $3.40BP/E –Yield –

Axogen, Inc. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
74.2%
Operating margin
-5.2%
Net margin
-12.0%
Return on equity, FY2025
-13.5%

Financial strength

Current ratio
12.02
Debt to equity
0.00
Debt to assets
0.0%
Cash to current liabilities
902.2%

Valuation

P/E ratio
–
Price to sales
12.74
Price to book
6.86
Dividend yield
–

See a number that looks wrong?